Vancomycin is named as an intervention in 2 current clinical trials in our UK and China registers. None are recruiting at the moment. The most common phase is Phase 1. The sponsor with the most trials is Microbiotica Ltd (1). The most-studied condition is Melanoma.
| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
Prospective, Randomized, Multicenter Clinical Trial of Bisphosphonates Combined With Vancomycin for the Treatment of Cierny-Mader Type I and III Osteomyelitis
NCT07435051 · ClinicalTrials.gov ↗ · Osteomyelitis (Refractory)
|
Phase 3 | Not yet open | Second Affiliated Hospital, Zhejiang University, School of Medicine | China |
|
A Phase 1b Trial to Evaluate Safety of MB097 in Combination With Pembrolizumab in Melanoma Patients
NCT06540391 · ClinicalTrials.gov ↗ · Melanoma
|
Phase 1 | Active, closed | Microbiotica Ltd | UK |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
The same active substance in our other registers, matched by its exact name. Each entry links to the register record it comes from.
15 single-substance products containing Vancomycin on the HPRA medicines list.
| Lead sponsor | Trials |
|---|---|
| Microbiotica Ltd | 1 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 1 |
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in UK | 1 | 0 |
| Clinical trials in China | 1 | 0 |
A trial with sites in more than one country appears in each of those registers.
2 current trials in our UK and China registers name Vancomycin as a drug or biological intervention, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.
Not at the moment. None of the 2 trials in our registers is recruiting; they are active but closed to enrolment, not yet open, or enrolling by invitation. Only the study team can confirm whether a patient is eligible.
Microbiotica Ltd (1) and Second Affiliated Hospital, Zhejiang University, School of Medicine (1). The number in brackets is how many trials each organisation leads.
Yes. The HPRA medicines list includes 15 single-substance products containing Vancomycin, for example Vancocin Matrigel 125mg Hard Capsules (Flynn Pharma Limited). A licence does not mean a product is currently marketed or reimbursed; see each product's record.
The registers we track list 2 entries for Vancomycin: US FDA: resolved; 1 German notice. Shortages are product- and country-specific; check with a pharmacist.
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Vancomycin works or whether it is effective, and it is not medical advice.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Vancomycin works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Vancomycin (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 26 Sep 2026.